2003
DOI: 10.1046/j.1523-1755.2003.00130.x
|View full text |Cite
|
Sign up to set email alerts
|

Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: Preliminary report

Abstract: These findings support our hypothesis that CCN2 is up-regulated early in the evolution of glomerulosclerosis, including that of diabetes. We contend that urinary CCN2 may both stage nephropathy and predict those patients who are destined for progressive glomerulosclerosis and end-stage renal disease (ESRD). Cross-sectional and prospective studies of larger, well-defined diabetic patients groups will be required to prove this hypothesis, and are ongoing.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
65
0
3

Year Published

2004
2004
2018
2018

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(74 citation statements)
references
References 42 publications
(46 reference statements)
6
65
0
3
Order By: Relevance
“…Another attractive report showed that urinary CTGF was upregulated in STZ rat prior to the development of albuminuria. 33 However, it remained to be elucidated whether CTGF could reflect glomerular structural changes especially in the early phase of diabetic nephropathy. In our study, we have confirmed that urinary Smad1 was closely correlated with the severity of mesangial matrix expansion in diabetic rats.…”
Section: Smad1 In Diabetic Nephropathymentioning
confidence: 99%
“…Another attractive report showed that urinary CTGF was upregulated in STZ rat prior to the development of albuminuria. 33 However, it remained to be elucidated whether CTGF could reflect glomerular structural changes especially in the early phase of diabetic nephropathy. In our study, we have confirmed that urinary Smad1 was closely correlated with the severity of mesangial matrix expansion in diabetic rats.…”
Section: Smad1 In Diabetic Nephropathymentioning
confidence: 99%
“…Expression of CTGF has been positively correlated with the degree of fibrosis, and indeed CTGF protein excretion in urine samples from patients with kidney disease has been identified as an effective indicator of renal function, with higher levels of CTGF protein reflecting increased renal damage (19,49).…”
mentioning
confidence: 99%
“…Several independent studies have evaluated CCN2 levels in the urine and/or serum in several chronic kidney diseases. Some groups have found elevated levels of the full-length CCN2, 5,6 or the N-terminal, 6,7 or the C-terminal [8][9][10] CCN2 fragments determined by ELISA, using antibodies that recognized each part of the molecule. Based on these data, CCN2 has been proposed as a risk biomarker of human diabetic nephropathy and other forms of chronic kidney disease, 2,5-10 and for cardiac dysfunction in patients exhibiting myocardial fibrosis and chronic heart failure.…”
mentioning
confidence: 99%